Statement 1 Adults who have had a fragility fracture or use systemic glucocorticoids or have a history of falls have an assessment of their fracture risk.
Statement 2 Adults at high risk of fragility fracture are offered drug treatment to reduce fracture risk.
Statement 3 Adults prescribed drug treatment to reduce fracture risk are asked about adverse effects and adherence to treatment at each medication review.
Statement 4 Adults having long-term bisphosphonate therapy have a review of the need for continuing treatment.
NICE has developed guidance and a quality standard on patient experience in adult NHS services (see the NICE pathway on patient experience in adult NHS services), which should be considered alongside these quality statements.
Other quality standards that should be considered when commissioning or providing osteoporosis services include:
A full list of NICE quality standards is available from the quality standards topic library.